May 28, 2020
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
AUSTIN, Texas–(BUSINESS WIRE)–Genprex, Inc. (“Genprex” or the “Company”) (Nasdaq: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for…
